Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer

Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of human equilibrative nucleoside transporter 1 (hENT1) is regarded as a potential predictive biomarker for a gemcitabine response in some cancers. This study was conducted to investigate the association bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jaihwan, Kim, Haeryoung, Lee, Jong-chan, Kim, Jin Won, Paik, Woo Hyun, Lee, Sang Hyub, Hwang, Jin-Hyeok, Ryu, Ji Kon, Kim, Yong-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296552/
https://www.ncbi.nlm.nih.gov/pubmed/30557411
http://dx.doi.org/10.1371/journal.pone.0209104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296552/
https://www.ncbi.nlm.nih.gov/pubmed/30557411
http://dx.doi.org/10.1371/journal.pone.0209104

Ejemplares similares